Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,734
Sort by:
Cancer Screening Market in the U.S.A. (2018-2023)
US$ 1,950.00
... in 5-10 business days after order is placed. Cancer screening market in the U.S.A. The United States Of America (U.S.A.) is leading the cancer screening market. The rising incidence of cancer along with growing awareness regarding ...
September 2018
75 pages
MEA Cancer Screening Market (2018-2023)
US$ 2,950.00
... after order is placed. Middle East and Africa cancer screening market The Middle East and Africa (MEA) cancer screening market is growing at a very slow rate. The MEA market is projected to reach USD 50.61 Bn by 2023, at a compound annual ...
September 2018
75 pages
Global Oncology Nutrition Market Size study, by Cancer (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood, Others) and by Regional Forecasts 2018-2025
US$ 3,150.00
... chemotherapy or any other treatments. The regional analysis of Global Oncology Nutrition Market is considered for the key regions such as Asia ... . Target Audience of the Global Oncology Nutrition Market in Market Study: Key Consulting Companies & Advisors Large, medium-sized, and small enterprises Venture ...
September 2018
120 pages
Global Cancer Immunotherapy Market - Forecasts from 2018 to 2023
US$ 3,950.00
... drugs for cancer immunotherapy. Adopting unhealthy living conditions and prevalence of cancer are driving the growth of the global cancer immunotherapy market. For ... ., Nektar, and Servier among others. Segmentation The global cancer immunotherapy market has been analyzed through following segments: By Type ...
September 2018
102 pages
Global Cancer Vaccine Market & Clinical Trial Insight 2025
US$ 3,000.00
... for cervical cancer and provenge for prostate cancer have already entered the market. Both the vaccines are therapeutic vaccines which have shown excellent outcome in the clinical trials. The ...
September 2018
700 pages
Global Eye Cancer Market Research and Forecast 2018-2023
US$ 3,600.00
... . Market Segmentation: Global Eye cancer market is segmented on the basis of regional outlook and following segments: 1. Global Eye cancer Market Research and Analysis, By Types 2. Global Eye cancer Market Research and Analysis, By Treatment 3. Global Eye cancer Market Research ...
August 2018
-
Promising Outlook - US Cancer Vaccine Market
US$ 1,400.00
... option. According to the RNCOS report entitled “Promising Outlook - US Cancer Vaccine Market”, the US is largest market for cancer vaccines amongst all the geographic regions ... has been segmented into three types, namely, liver cancer, HPV related cancer, and others. On the basis of type of vaccine, the market ...
August 2018
135 pages
China Cancer Drugs Market, by Drugs [Cytotoxic Drugs (Antimetabolities, Plant Alkaloids, Alkylating Agents), Targeted Drugs, Monoclonal Antibiotics, Hormonal Drugs, Traditional Chinese Medicine (TCM), & Others], Cancer (Lung, Stomach, Breast, Esophageal, Liver & Others), Therapy (Chemotherapy, Targeted Therapy, Hormonal Therapy & Others), Companies (Merck, Celgene, Eli Lilly, Roche & Sino BioPharma)
US$ 1,990.00
... forecast period By therapy type, the China anti-cancer drugs market is segmented into chemotherapy, targeted therapy, hormonal therapy and others. Chemotherapy and targeted therapy together held the major share of China cancer drugs market. Company ...
August 2018
-
Breast Cancer Screening Market, Population, By Screening Tests [Mammography, Magnetic Resonance Imaging (MRI) & Ultrasound] By Countries (United States, Canada, United Kingdom, France, Germany, Italy, Spain, Netherlands, Norway, Switzerland, India, China, Japan, Korea, Singapore, Thailand, Malaysia, Brazil, Australia, New Zealand)
US$ 1,590.00
... organizations & biotechnology. Renub Research latest study report “Breast Cancer Screening Market, Population, By Screening Tests [Mammography, Magnetic Resonance Imaging (MRI) & Ultrasound] By Countries (United States, Canada, United Kingdom, France ...
July 2018
-
Global Cancer Gene Therapy Market Research and Forecast 2018-2023
US$ 3,600.00
... . MARKET SEGMENTATION: Global Cancer gene therapy market is segmented on the basis of regional outlook and following segments: Global Cancer gene therapy Market Research and Analysis, By Therapy Global Cancer gene therapy Market Research and Analysis, By End Users Global Cancer gene therapy Market Research ...
July 2018
-
Report Package Immuno-Oncology: Inhibitory and Stimulatory Immunomodulators
US$ 1,690.00
Report Package Immuno-Oncology: Inhibitory and Stimulatory Immunomodulators This product consists of four reports in pdf ... include compilations of currently active projects in research and development of immunomodulators in immuno-oncology. In addition, each report lists company-specific R&D pipelines of ...
July 2018
455 pages
2018 Italy Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 6,700.00
... business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, ... market dynamics, structure, size, growth and major suppliers. Estimated universe of laboratories performing cancer diagnostic testing. Cancer statistics, etiology and recent developments in Italy ...
June 2018
570 pages
2018 US Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 9,800.00
... ; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the US cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field ...
June 2018
620 pages
2018 France Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 6,700.00
... business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, ... market dynamics, structure, size, growth and major suppliers. Estimated universe of laboratories performing cancer diagnostic testing. Cancer statistics, etiology and recent developments in France ...
June 2018
585 pages
2018 Germany Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 6,700.00
... business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, ... market dynamics, structure, size, growth and major suppliers. Estimated universe of laboratories performing cancer diagnostic testing. Cancer statistics, etiology and recent developments in Germany ...
June 2018
585 pages
2018 Japan Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 8,800.00
... business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, ... market dynamics, structure, size, growth and major suppliers. Estimated universe of laboratories performing cancer diagnostic testing. Cancer statistics, etiology and recent developments in Japan ...
June 2018
590 pages
2018 Spain Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 6,700.00
... business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, ... market dynamics, structure, size, growth and major suppliers. Estimated universe of laboratories performing cancer diagnostic testing. Cancer statistics, etiology and recent developments in Spain ...
June 2018
565 pages
2018 UK Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 6,700.00
... ; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the UK cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field ...
June 2018
565 pages
2018 Europe Cancer Diagnostics Market Segmentation Analysis: France, Germany, Italy, Spain, UK--Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 19,700.00
... identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the ... universe of laboratories performing cancer diagnostic testing by country. Cancer statistics, etiology and recent developments in Europe. Business Opportunities and Strategic ...
June 2018
820 pages
Kidney Cancer Drugs Market Size, Share & Trends Analysis Report By Therapeutic Class (Targeted Therapy, Immunotherapy), By Pharmacologic Class, By Country, And Segment Forecasts, 2016 - 2022
US$ 5,950.00
... kidney cancer drugs market size is expected to be valued at USD 6.3 billion by 2022, as per a new report by Grand View Research, Inc., registering a CAGR of 5.4% during the forecast period. Market ... hand, surge in kidney cancer screening is a key driver in markets such as EU Emerging markets in Asia Pacific and ...
June 2018
99 pages
Asia Cervical Cancer Diagnostic Market, By Test Type (Pap smear, HPV DNA and VIA), Countries (Japan, Korea, Singapore, Malaysia, India, China, Thailand and Indonesia) & Forecast
US$ 1,290.00
... cancer test market in the developing countries. Renub Research report titled “Asia Cervical Cancer Diagnostic Market, By Test Type (Pap smear, HPV DNA and VIA), Countries (Japan, Korea, Singapore, Malaysia, India, China, Thailand and Indonesia) & Forecast” provides a complete analysis of Asia Cervical Cancer ...
June 2018
-
Europe Cervical Cancer Diagnostic Market & Forecast, By Test Type (Pap smear and HPV DNA), Countries (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway and Netherlands)
US$ 1,290.00
... Cancer Diagnostic Market & Forecast, By Test Type (Pap smear and HPV DNA), Countries (United Kingdom, France, Germany, Italy, Spain, Sweden, Switzerland, Norway and Netherlands)” provides a complete analysis of Europe Cervical Cancer Screening Market. The covers European Countries Cervical Cancer Test Market ...
June 2018
-
2018 Europe Cancer Diagnostics Market: France, Germany, Italy, Spain, UK--Supplier Shares and Sales Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
US$ 19,700.00
... suggests alternative business expansion strategies for suppliers.strong> RationaleThe cancer diagnostics market is on the verge of explosion, as the researchers ... of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding ...
June 2018
820 pages
Colorectal Cancer (CRC) Drugs/ Therapeutic Market Size, Share & Trends Analysis Report by Drug Class (Chemotherapy, Immunotherapy), By Country (U.S., U.K., Germany, Spain, Italy, France, Japan), And Segment Forecasts, 2016 - 2022
US$ 5,950.00
The global colorectal cancer (CRC) drugs market size is expected to reach ... some of the unmet needs of the colorectal cancer (CRC) market. If approved, Array Biopharma’s ... drugs Roche led the colorectal cancer industrial setting in 2016 due to growing usage of Avastin. Avastin was the highest revenue-generating CRC ...
June 2018
99 pages
Vulvar Cancer - Pipeline Review, H1 2018
US$ 2,000.00
... releases. The Vulvar Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Vulvar Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
May 2018
125 pages
Wilms Tumor Protein (WT33 or WT1) - Pipeline Review, H1 2018
US$ 3,500.00
... Wilms Tumor Protein (WT33 or WT1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...
May 2018
65 pages
Ovarian Cancer Drugs Market Size, Share & Trends Analysis Report By Therapeutic Class (PARP, PD-L1 Inhibitors , Angiogenesis), By Major Markets (U.S., U.K., Germany, Spain, Italy, France, Japan), And Segment Forecasts, 2016 - 2022
US$ 5,950.00
The global ovarian cancer drugs market size is expected to be valued at USD 4.5 billion by 2022, as per a new report by Grand ... to be the upcoming milestones for ovarian cancer treatment PARP inhibitors are anticipated to be the fastest growing drug class in the ovarian cancer market through the forecast period ...
May 2018
94 pages
Breast Cancer: KOL Insight [2018]
US$ 8,495.00
... triple-negative breast cancer and the potential usage of PD-1/PD-L1 checkpoint inhibitors is also explored. Twelve US and EU KOLs offer their candid insights on these ... how checkpoint inhibitors may be used in triple-negative breast cancer (TNBC). What are KOLs’ thoughts on these agents and how do they ...
April 2018
-
Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023
US$ 16,000.00
... .” Based on cancer type, the oncology nutrition market is segmented into head & neck cancers, stomach & gastrointestinal cancers, pancreatic cancer, liver cancer, esophageal cancer, lung cancer, breast cancer, blood cancer, and other cancers. The ...
April 2018
97 pages
